The Asian IVD instruments market is growing due to the ongoing developments in analytical laboratory automation; the swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology.
The report analyzes the market in terms of segments such as high-risk and risk devices, and devices for self testing, among others.
The most important trend witnessed recently in the IVD industry is the trend of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing so as to avoid unnecessary visits to the hospital. IVD Instruments accounted for 21.3% share of the overall IVD market in 2013. Routine tests such as testing for blood albumin, ALT/SGPT, ammonia, blood gases, and calcium & creatinine levels are required before undergoing advanced tests. IVD instruments tests thereby form the center stage of the overall IVD market.
The major changes in this sector have been brought about as a result of the convergence of system engineering, automation, and IT technologies. Thus, these new technologies have enabled a better understanding of disease processes. The IVD instruments market is expanding, consolidating, and becoming highly competitive with a myriad of opportunities for various new instruments, reagents, calibrators, and other systems.
In the emerging countries of the region, the growing awareness, along with the increasing middle-class population and higher disposable incomes to spend on healthcare, is expected to drive the growth of this market in the coming years.
The report also provides an extensive competitive landscaping of the leading companies operating in this market. The main companies that are extensively covered in this report are Abbott Laboratories, Inc., Alere, Inc., Arkray, Inc., Bayer Ag, Becton, Dickinson And Company, Biomerieux, Bio-Rad Laboratories, Inc., Danaher Corporation, Diagnostica Stago Sas, Diasorin S.P.A., Hologic, Inc., Horiba, Johnson & Johnson, Novartis International Ag, Qiagen N.V., Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, and Thermo Fisher Scientific, Inc., among others. Furthermore, segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Along with market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and deep dive analysis of the following parameters:
- Unmet needs, revenue pockets, and potential areas for expansion
Lab testing Data
- Number of IVD tests performed annually in each country, tracked till sub-segment level
- Pricing trend of IVD instruments
Current and Emerging Products
- An analysis of current and emerging IVD instruments and immunodiagnostic tests
- Review of current instrumentation technologies
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment levels
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Brand/Product Perception Matrix
- A comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
- An analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such as patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure).
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
North America In Vitro Diagnostics
In 2013, the Americas had the largest market, a 42% share of the Global IVD market, followed by Europe with a 31% share. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets. The report “North American In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users.
Europe In Vitro Diagnostics
In 2013, the Americas had the largest market, a 42% share of the European IVD market, followed by Europe with a 31% share. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets. The report “European In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users. Germany commanded the largest share in European IVD market.
Asia In Vitro Diagnostics
Asian IVD market is growing in double digit and will continue to grow in future. China commanded the largest share in Asian IVD market. The report “Asian In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users.